Buying Peptides Online: What the Grey Market Actually Ships

Search for semaglutide, sermorelin or NAD+, and you will find two kinds of sellers sitting side by side in the results. One asks about your medical history, requires a prescription, and charges clinic prices. The other ships a vial with the same molecule name on the label, marked "for research use only," at a fraction of the cost, no questions asked.

The price gap is real. The question is what you are actually paying for. Independent laboratories have purchased and tested what the cheap vials contain, so this does not have to be a matter of opinion. This article walks through that evidence, explains how the tiers of peptide sellers differ legally and practically, and ends with a checklist you can use to vet any provider, including us. New to the topic? Start with our plain-English guide to what a peptide is.

The three tiers of peptide sellers

Tier 1: "Research use only" vendors. These sites sell peptides as laboratory chemicals. No prescription, no pharmacist, no physician, and a label that says "not for human consumption." That label is a legal shield, not a quality standard: it is an attempt to avoid being regulated as a drug seller. The FDA has stopped accepting the fiction. In December 2024 it sent warning letters to five online peptide vendors selling semaglutide, tirzepatide and related compounds, writing that despite the research-use labels, "evidence gathered by the FDA establishes that these products are actually intended to be used as drugs for humans." No agency verifies what is in these vials before they ship.

Tier 2: Licensed clinics working with licensed pharmacies. Here a US-licensed clinician reviews your health history and writes a patient-specific prescription, which is filled by a state-licensed compounding pharmacy (a 503A pharmacy, overseen by state boards of pharmacy with FDA inspection authority) or an FDA-registered 503B outsourcing facility, which must follow the same manufacturing standards as drug makers. This is the tier Faber operates in. To be precise about what this tier is not: compounded medications are not FDA-approved products. What the tier provides is a regulated chain of custody, with a licensed prescriber and a licensed pharmacy legally accountable for what reaches you.

Tier 3: FDA-approved brand products. Ozempic, Mounjaro, Wegovy and other approved drugs have passed full FDA review of safety, effectiveness and manufacturing. This is the highest bar and the highest price, and for many patients insurance does not cover it.

What independent labs found in grey market vials

The most rigorous recent test came from a university research team that ordered semaglutide from six illegal online vendors and published the results in 2024 in JAMA Network Open and the Journal of Medical Internet Research. Three of the six orders never arrived at all; the sellers instead demanded fake "customs clearance" payments of $650 to $1,200. The three vials that did arrive were tested in a laboratory:

• Purity was 7% to 14%, against an advertised 99%.
• The actual semaglutide content was 29% to 39% higher than the labeled dose. With a potent metabolic drug, getting more than the label says is an overdose risk, not a bonus.
• Every delivered sample contained detectable bacterial endotoxins, which you do not want in anything you inject.

This is not a one-off. In 2018, Belgium's national health laboratory published an analysis of 27 illicit peptide preparations from suspected illegal internet pharmacies, covering products sold as ipamorelin, sermorelin, CJC-1295, melanotan II, TB-500 and others. Purity ran as low as 5% to 46% for some products. Six of the 27 samples exceeded safety limits for arsenic, in the worst case by roughly ten times. Vials sold as the peptide fragment TB-500 contained a different, full-length molecule entirely. An earlier 2015 study bought melanotan II from three online shops: every vial was labeled 10 mg, and the actual content ranged from 4.3 to 8.8 mg, with unidentified impurities in most.

The pattern across a decade of testing is consistent. With grey market peptides, the dose you draw into a syringe is unknown in both directions, and purity claims on the website bear no reliable relationship to the vial.

Counterfeits have reached even pharmacy shelves

The problem is not limited to obscure websites. In December 2023 the FDA seized thousands of counterfeit Ozempic units that had entered the legitimate US drug supply chain, with further seizures announced in 2025. The World Health Organization issued a global alert in June 2024 covering falsified semaglutide found in the US, UK and Brazil, and noted rising reports worldwide since 2022, including counterfeit pens that contained undeclared insulin, which can cause dangerous hypoglycemia. If counterfeiters are willing to target regulated pharmacy channels, an unregulated website with no accountable pharmacist is a far softer target.

Dosing errors are where people actually get hurt

Contamination gets the headlines, but the most common way people are harmed is simpler: they inject the wrong amount. US poison control centers took nearly 3,000 calls involving semaglutide in the first eleven months of 2023, roughly fifteen times the 2019 level, and the majority involved dosing errors such as accidental double doses. The FDA's adverse event database held 990 reports associated with compounded semaglutide and more than 730 for compounded tirzepatide as of May 2026, including dosing errors that led to hospitalization.

A vial, an insulin syringe and no instructions is a unit conversion problem waiting to happen. This is the practical argument for physician oversight: not gatekeeping, but titration schedules, unit math checked by a clinician, and someone to call when side effects appear.

What a licensed clinic gives you, and what it still does not

We will be as blunt about our own tier as about the grey market. The FDA states plainly that it "does not verify the safety, effectiveness or quality of compounded drugs before they are marketed." Quality among compounding pharmacies varies, and drug makers have sued pharmacies over impure compounded samples (though manufacturer-funded testing deserves the same skepticism as any interested party's data). The regulatory environment for compounded GLP-1s specifically has tightened since the brand-drug shortages were declared resolved in 2024 and 2025, and the FDA moved against large-scale GLP-1 compounding in 2026. Any clinic in this space owes you clarity about how it sources and tests what it sells.

What the licensed tier does provide: a clinician legally responsible for the prescription, a pharmacy legally responsible for the product, purity and sterility standards with inspection authority behind them, batch documentation, and a dosing protocol with follow-up. None of that exists in Tier 1 at any price.

Seven questions to ask before you buy from anyone

1. Does a US-licensed clinician review my health history before I can order?
2. Which pharmacy fills the prescription, and is it state-licensed or FDA-registered?
3. Can I see a certificate of analysis for my batch, from an independent lab?
4. Is the dose I receive labeled in mg, with a titration plan in writing?
5. Is there a clinician I can reach if I have side effects?
6. Does the seller claim its product is "FDA approved"? For compounded drugs, that claim is false and a red flag in itself.
7. Does the label say "research use only"? If yes, no one has verified the vial's contents for human use. Walk away.

The bottom line

The discount on a grey market vial is not a discount on the same product. Published laboratory testing shows it is frequently a different product: underdosed, overdosed, impure, or not the labeled molecule at all. What a legitimate clinic charges for is the licensed chain of custody between a prescriber, a pharmacy and your syringe. That is the entire difference, and in this category it is the difference that matters.

This article is for general education and is not medical advice. Peptide therapies are prescription treatments with real side effects and are not appropriate for everyone. Talk to a licensed clinician about whether any treatment discussed here fits your health situation.